Buy Aurobindo Pharma, price target Rs 495: CK Narayan
The analyst suggested a stop loss at Rs 472.

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 28145.56 Crore) operating in Pharmaceuticals sector.
Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11922.63 Crore to Sales Value (97.26 % of Total Sales), Export Incentives which contributed Rs 303.72 Crore to Sales Value (2.47 % of Total Sales), Sale of services which contributed Rs 16.07 Crore to Sales Value (0.13 % of Total Sales) and Scrap which contributed Rs 15.47 Crore to Sales Value (0.12 % of Total Sales) for the year ending 31-Mar-2019.
For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 5518.27 Crore, up 3.01 % from last quarter sales of Rs 5356.84 Crore and up 18.24 % from last year same quarter sales of Rs 4667.12 Crore. Company has reported net profit after tax of Rs 639.46 Crore in latest quarter.
Download ET Markets APP